AI is transforming pharma manufacturing—but Quality Control is still stuck in the past.
Today’s sterility testing and environmental monitoring rely on slow, manual, and fragmented workflows that cannot support real-time, data-driven operations. As production moves to continuous, risk-based models, QC is becoming the critical bottleneck, with a significant impact on the financial performance of the entire site.
The uncomfortable truth: you cannot run a 21st-century operation with 19th-century microbiology!
This session will challenge leaders to rethink Quality Control—from a neglected bottleneck to a competitive advantage—through automation, digitalisation, and rapid microbiology. Despite its critical role, contamination control is rarely treated as a strategic lever, and its impact on performance is consistently underestimated. In the age of AI, waiting is no longer a strategy.
